
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 420
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT01164189 | Bevacizumab in Recurrent Grade II and III Glioma | ||
NCT01905592 | A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients | ||
NCT00003989 | ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma | ||
NCT00066391 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | ||
NCT00028691 | Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma | ||
NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia | ||
NCT02446444 | Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer | ||
NCT05270044 | Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. | ||
NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) | ||
NCT03563040 | Study of Photopheresis in the Treatment of Erythrodermic MF and SS | ||
NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | ||
NCT01244789 | Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer | ||
NCT00949962 | Post-operative or Early Salvage XRT and ADT for High Risk PCa | ||
NCT00030680 | Radiation Therapy in Treating Patients With Aggressive Fibromatoses | ||
NCT00049660 | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | ||
NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | ||
NCT00002840 | Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | ||
NCT00005980 | Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer | ||
NCT05209529 | Chemo-free BRCA-targeted Neoadjuvant Strategy | ||
NCT00003729 | Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia | ||
NCT02546544 | Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma | ||
NCT00450892 | Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer | ||
NCT00003140 | Letrozole After Tamoxifen in Treating Women With Breast Cancer | ||
NCT00022594 | Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer | ||
NCT02929394 | Trabectedin Maintenance Post 1st-line in STS | ||
NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | ||
NCT00027794 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | ||
NCT03770468 | Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma | ||
NCT02504372 | Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091) | ||
NCT00003640 | Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | ||
NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | ||
NCT00948389 | Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM) | ||
NCT00433589 | Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes | ||
NCT00002989 | Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome | ||
NCT00002972 | Paclitaxel in Treating Patients With Lung Cancer | ||
NCT02172872 | "InDACtion" vs "3+7" Induction in AML | ||
NCT01850004 | Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response | ||
NCT04128072 | Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma | ||
NCT00091572 | Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267) | ||
NCT00003772 | Quality-of-Life Assessment in Patients With Ovarian Cancer | ||
NCT02218801 | A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program | ||
NCT00003267 | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer | ||
NCT00036868 | Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | ||
NCT00103168 | Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor | ||
NCT00005868 | Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer | ||
NCT00003982 | MEN-10755 in Treating Patients With Solid Tumors | ||
NCT00022620 | Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer | ||
NCT00062231 | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer | ||
NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | ||
NCT06978062 | Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment |